Radioembolization

Radioembolization is an innovative minimally invasive method for treating liver cancer, involving the injection of radioactive spheres into the blood vessels supplying the tumor. It is used as a treatment for primary liver cancer, such as hepatocellular carcinoma and cholangiocarcinoma, as well as for secondary liver cancer in cases of metastases resistant to standard chemotherapy.

Radioembolization stops the growth of malignant liver tumors in 90% of patients, increasing their life expectancy by 4–5 times compared to other treatment methods.

Features of the procedure in leading clinics

In the world’s top clinics, liver radioembolization has become an alternative to chemoembolization in cases of portal vein thrombophlebitis and large tumors. Additionally, the injection of radioactive micro-emboli into blood vessels serves as a modern preparatory method for organ transplantation.

Leading European hospitals use modern embolization agents, such as albumin-based microspheres saturated with rhenium. All patients treated with this medication show positive therapeutic responses without side effects.